Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.
Aronne LJ, Tonstad S, Moreno M, Gantz I, Erondu N, Suryawanshi S, Molony C, Sieberts S, Nayee J, Meehan AG, Shapiro D, Heymsfield SB, Kaufman KD, Amatruda JM. Aronne LJ, et al. Among authors: heymsfield sb. Int J Obes (Lond). 2010 May;34(5):919-35. doi: 10.1038/ijo.2010.21. Epub 2010 Feb 16. Int J Obes (Lond). 2010. PMID: 20157323 Clinical Trial.
Electrocardiographic QTC interval: short-term weight loss effects.
Pietrobelli A, Rothacker D, Gallagher D, Heymsfield SB. Pietrobelli A, et al. Among authors: heymsfield sb. Int J Obes Relat Metab Disord. 1997 Feb;21(2):110-4. doi: 10.1038/sj.ijo.0800374. Int J Obes Relat Metab Disord. 1997. PMID: 9043964
HCA efficiency.
Heymsfield SB, Aronne LJ, Blackburn GL. Heymsfield SB, et al. Diabetes Obes Metab. 2004 Nov;6(6):458-9; author reply 460-1. doi: 10.1111/j.1462-8902.2004.00423.x. Diabetes Obes Metab. 2004. PMID: 15479223 No abstract available.
808 results